These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

301 related items for PubMed ID: 15140182

  • 1. Genetic ablation of tumor necrosis factor-alpha (TNF-alpha) and pharmacological inhibition of TNF-synthesis attenuates MPTP toxicity in mouse striatum.
    Ferger B, Leng A, Mura A, Hengerer B, Feldon J.
    J Neurochem; 2004 May; 89(4):822-33. PubMed ID: 15140182
    [Abstract] [Full Text] [Related]

  • 2. Selective alterations of gene expression in mice induced by MPTP.
    Xu Z, Cawthon D, McCastlain KA, Slikker W, Ali SF.
    Synapse; 2005 Jan; 55(1):45-51. PubMed ID: 15499605
    [Abstract] [Full Text] [Related]

  • 3. Gender differences on MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) neurotoxicity in C57BL/6 mice.
    Ookubo M, Yokoyama H, Kato H, Araki T.
    Mol Cell Endocrinol; 2009 Nov 13; 311(1-2):62-8. PubMed ID: 19631714
    [Abstract] [Full Text] [Related]

  • 4. Mice lacking alpha-synuclein have an attenuated loss of striatal dopamine following prolonged chronic MPTP administration.
    Drolet RE, Behrouz B, Lookingland KJ, Goudreau JL.
    Neurotoxicology; 2004 Sep 13; 25(5):761-9. PubMed ID: 15288507
    [Abstract] [Full Text] [Related]

  • 5. Mice deficient in TNF receptors are protected against dopaminergic neurotoxicity: implications for Parkinson's disease.
    Sriram K, Matheson JM, Benkovic SA, Miller DB, Luster MI, O'Callaghan JP.
    FASEB J; 2002 Sep 13; 16(11):1474-6. PubMed ID: 12205053
    [Abstract] [Full Text] [Related]

  • 6. Minocycline attenuates microglial activation but fails to mitigate striatal dopaminergic neurotoxicity: role of tumor necrosis factor-alpha.
    Sriram K, Miller DB, O'Callaghan JP.
    J Neurochem; 2006 Feb 13; 96(3):706-18. PubMed ID: 16405514
    [Abstract] [Full Text] [Related]

  • 7. Neuroprotective effects of (+/-)-kavain in the MPTP mouse model of Parkinson's disease.
    Schmidt N, Ferger B.
    Synapse; 2001 Apr 13; 40(1):47-54. PubMed ID: 11170221
    [Abstract] [Full Text] [Related]

  • 8. MPTP-induced model of Parkinson's disease in cytochrome P450 2E1 knockout mice.
    Viaggi C, Vaglini F, Pardini C, Caramelli A, Corsini GU.
    Neuropharmacology; 2009 Jun 13; 56(8):1075-81. PubMed ID: 19298832
    [Abstract] [Full Text] [Related]

  • 9. Nrf2 regulates microglial dynamics and neuroinflammation in experimental Parkinson's disease.
    Rojo AI, Innamorato NG, Martín-Moreno AM, De Ceballos ML, Yamamoto M, Cuadrado A.
    Glia; 2010 Apr 13; 58(5):588-98. PubMed ID: 19908287
    [Abstract] [Full Text] [Related]

  • 10. Alteration of dopaminergic markers in gastrointestinal tract of different rodent models of Parkinson's disease.
    Tian YM, Chen X, Luo DZ, Zhang XH, Xue H, Zheng LF, Yang N, Wang XM, Zhu JX.
    Neuroscience; 2008 May 15; 153(3):634-44. PubMed ID: 18420351
    [Abstract] [Full Text] [Related]

  • 11. Deficiency of TNF receptors suppresses microglial activation and alters the susceptibility of brain regions to MPTP-induced neurotoxicity: role of TNF-alpha.
    Sriram K, Matheson JM, Benkovic SA, Miller DB, Luster MI, O'Callaghan JP.
    FASEB J; 2006 Apr 15; 20(6):670-82. PubMed ID: 16581975
    [Abstract] [Full Text] [Related]

  • 12. Tripchlorolide protects against MPTP-induced neurotoxicity in C57BL/6 mice.
    Hong Z, Wang G, Gu J, Pan J, Bai L, Zhang S, Chen SD.
    Eur J Neurosci; 2007 Sep 15; 26(6):1500-8. PubMed ID: 17714494
    [Abstract] [Full Text] [Related]

  • 13. Effects of blocking the dopamine biosynthesis and of neurotoxic dopamine depletion with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on voluntary wheel running in mice.
    Leng A, Mura A, Hengerer B, Feldon J, Ferger B.
    Behav Brain Res; 2004 Oct 05; 154(2):375-83. PubMed ID: 15313025
    [Abstract] [Full Text] [Related]

  • 14. Dehydroepiandrosterone (DHEA) such as 17beta-estradiol prevents MPTP-induced dopamine depletion in mice.
    D'Astous M, Morissette M, Tanguay B, Callier S, Di Paolo T.
    Synapse; 2003 Jan 05; 47(1):10-4. PubMed ID: 12422368
    [Abstract] [Full Text] [Related]

  • 15. Tyrosine hydroxylase and dopamine transporter expression following 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurodegeneration of the mouse nigrostriatal pathway.
    Jakowec MW, Nixon K, Hogg E, McNeill T, Petzinger GM.
    J Neurosci Res; 2004 May 15; 76(4):539-50. PubMed ID: 15114626
    [Abstract] [Full Text] [Related]

  • 16. Chemokines in the MPTP model of Parkinson's disease: absence of CCL2 and its receptor CCR2 does not protect against striatal neurodegeneration.
    Kalkonde YV, Morgan WW, Sigala J, Maffi SK, Condello C, Kuziel W, Ahuja SS, Ahuja SK.
    Brain Res; 2007 Jan 12; 1128(1):1-11. PubMed ID: 17126305
    [Abstract] [Full Text] [Related]

  • 17. Tumor necrosis factor-alpha receptor ablation in a chronic MPTP mouse model of Parkinson's disease.
    Leng A, Mura A, Feldon J, Ferger B.
    Neurosci Lett; 2005 Feb 28; 375(2):107-11. PubMed ID: 15670651
    [Abstract] [Full Text] [Related]

  • 18. Environmental enrichment in adulthood eliminates neuronal death in experimental Parkinsonism.
    Faherty CJ, Raviie Shepherd K, Herasimtschuk A, Smeyne RJ.
    Brain Res Mol Brain Res; 2005 Mar 24; 134(1):170-9. PubMed ID: 15790541
    [Abstract] [Full Text] [Related]

  • 19. Absence of MPTP-induced neuronal death in mice lacking the dopamine transporter.
    Bezard E, Gross CE, Fournier MC, Dovero S, Bloch B, Jaber M.
    Exp Neurol; 1999 Feb 24; 155(2):268-73. PubMed ID: 10072302
    [Abstract] [Full Text] [Related]

  • 20. Neuroprotective properties of 17beta-estradiol, progesterone, and raloxifene in MPTP C57Bl/6 mice.
    Callier S, Morissette M, Grandbois M, Pélaprat D, Di Paolo T.
    Synapse; 2001 Aug 24; 41(2):131-8. PubMed ID: 11400179
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.